Platinum-based therapy in men with metastatic castration resistant prostate (mCRPC) with or without DNA repair defects: a multicentre retrospective analysis
Authors
Gillessen, SilkeSchmid, S
Beltran, H
Almeida, D
Mehra, N
Lavaud, P
Barrera, R
Pignataro, D
Marcos, E
Conteduca, V
Efstathiou, E
Le, HML
Pezaro, C
Suzuki, H
Zivi, A
Klingbiel, D
Omlin, A
Affiliation
Division of Cancer Sciences, University of Manchester and the Christie, Manchester, UKIssue Date
2018
Metadata
Show full item recordCitation
Gillessen S, Schmid S, Beltran H, Almeida DVP, Mehra N, Lavaud P, et al. 814P Platinum-based therapy in men with metastatic castration resistant prostate (mCRPC) with or without DNA repair defects: a multicentre retrospective analysis. Ann Oncol. 2018;29(suppl_8):282.Journal
Annals of OncologyDOI
10.1093/annonc/mdy284.023Additional Links
https://dx.doi.org/10.1093/annonc/mdy284.023Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdy284.023